Quantitative airway assessment on computed tomography in patients with α1-antitrypsin deficiency

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 6, 2009, Pages 468-477

  Yamashiro, Tsuneo ^a,e   Matsuoka, Shin ^a   Estpar, Ral San Jos ^a   Diaz, Alejandro ^a,b   Newell, John D ^c   Sandhaus, Robert A ^c   Mergo, Patricia J ^d   Brantly, Mark L ^d   Murayama, Sadayuki ^e   Reilly, John J ^f   Hatabu, Hiroto ^a   Silverman, Edwin K ^a   Washko, George R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF THE RYUKYUS   (Japan)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

1 = antitrypsin deficiency; Chronic obstructive pulmonary disease; Computed topography; Pulmonary emphysema; Small airway disease

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; FEMALE; HUMAN; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

ALPHA 1-ANTITRYPSIN DEFICIENCY; ANALYSIS OF VARIANCE; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; MALE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMPHYSEMA; PULMONARY VENTILATION; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73549118998     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412550903341521     Document Type: Article

References (30)

1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:818-900.
2. Shaker SB, Stavngaard T, Stolk J, Stoel B, Dirksen A. 1- antitrypsin deficiency.7: Computed tomographic imaging in 1- antitrypsin deficiency. Thorax 2004; 59:986-991.
3. Stavngaard T, Shaker SB, Dirksen A. Quantitative assessment of emphysema distribution in smokers and patients with α1- antitrypsin deficiency. Respir Med 2006; 100:94-100. (Pubitemid 43033385)
4. Parr DG, Sevenoaks M, Deng CQ, Stoel BC, Stockley RA. Detection of emphysema progression in α 1-antitrypsin deficiency using CT densitometry: methodological advances. Respir Res 2008; 9:21.
5. Dowson LJ, Guest PJ, Hill SL, Holder RL, Stockley RA. Highresolution computed tomography scanning in α1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J 2001; 17:1097-1104.
6. Parr DG, Stoel BC, Stolk J, Stockley RA. Pattern of emphysema distribution in α1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 2004; 170:1172-1178.
7. Stolk J, Ng WH, Bakker ME, Reiber JH, Rabe KF, Putter H, Stoel BC. Correlation between annual change in health status and computer tomography derived lung density in subjects with α1-antitrypsin deficiency. Thorax 2003; 58:1027-1030.
8. Dirkson A, Dijkman JH, Madsen F, Stoel B, Hutchinson DC, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, Vrooman HA, Reiber JH, Hansen NC, Heckscher T, Viskum K, Stolk J. A randomized clinical trial of α1- antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999; 160:1468-1472.
9. Parr DG, Stoel BC, Stolk J, Stockley RA. Validation of computed tomographic lung densitometry for monitoring emphysema in α1- antitrypsin deficiency. Thorax 2006; 61:485-490.
10. Dowson LJ, Guest PJ, Stockley RA. The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in α1-antitrypsin deficiency (PiZ). Chest 2002; 122:1247-1255.
11. Hasegawa M, Nasuhara Y, Onodera Y, Makita H, Nagai K, Fuke S, Ito Y, Betsuyaku T, Nishimura M. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:1309-1315.
12. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Ito H, Pare PD, Hogg JC, Mishima M. Computed tomographic measurements of airway dimensions and emphysema in smokers. Am J Respir Crit Care Med 2000; 162:1102-1108.
13. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagano T, Coxson HO, Elliot WM, Hogg JC, Pare PD. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005; 171:142-146.
14. Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Nakajima Y. Airway dimensions at inspiratory and expiratory multisection CT in chronic obstructive pulmonary disease: correlation with airflow limitation. Radiology 2008; 248:1042-1049.
15. Cuvelier A, Muir JF, Hellot MF, Benhamou D, Martin JP, Benichou J, Sesboue R. Distribution of α1-antitrypsin alleles in patients with bronchiectasis. Chest 2000; 117:415-419.
16. Guest PJ, Hansell DM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 1992; 45:260-266.
17. Shin MS, Ho KJ. Bronchiectasis in patients with α1-antitrypsin deficiency: a rare occurrence? Chest 1993; 104:1384-1386.
18. King MA, Stone JA, Diaz PT, Mueller CF, Becker WJ, Gadek JE. α1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996; 199:137-141.
19. Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in α1-antitrypsin deficiency. Am J Respir Crit Care Med 2007; 176:1215-1221.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
21. Dransfield MT, Washko GR, Foreman MG, San Jose Estepar R, Reilly J, Bailey WC. Gender differences in the severity of CT emphysema in COPD. Chest 2007; 132:464-470.
22. Black LF, Hyatt RE, Stubbs SE. Mechanism of expiratory airflow limitation in chronic obstructive pulmonary disease associated with α1-antitrypsin deficiency. Am Rev Respir Dis 1972; 105:891-899.
23. Eden E, Mitchell D, Mehlman B, Khouli H, Mejat M, Grieco MH, Turino GM. Atopy, asthma, and emphysema in patients with severe α1-antitrypsin deficiency. Am J Respir Crit Care Med 1997; 156:68-74.
24. McElvaney NG, Stoller JK, Buist AS, Prakash UB, Brantly ML, Schluchter MD, Crystal RD, α1-antitrypsin deficiency registry study group. Baseline characteristics of enrollees in the National Heart, Lung, and Blood Institute Registry of α1-antitrypsin deficiency. Chest 1997; 111:394-403.
25. DeMeo DL, Sandhaus RA, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard S, Burchard E, Stocks JM, Stoller JK, Strange C, Turino GM, Campbell EJ, Silverman EK. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax 2007; 62:806-813.
26. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:478-485. (Pubitemid 351669174)
27. Hogg JC, Chu F, Utokaparch S, Woods R, Elliot WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653.
28. Ooi GC, Khong PL, Chan-Yeung M, Ho JC, Chan PK, Lee JC, Lam WK, Tsang KW. High-resolution CT quantification of bronchiectasis: clinical and functional correlation. Radiology 2002; 225:663-672.
29. Lynch DA, Newell J, Hale V, Dyer D, Corkery K, Fox NL, Gerend P, Fick R. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. Am J Roentognol 1999; 173:53-58.
30. Kim WD, Ling SH, Coxson HO, English JC, Yee J, Levy RD, Pare PD, Hogg JC. The association between small airway obstruction and emphysema phenotypes in COPD. Chest 2007; 131:1372-1378.